TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement

NCT02505399 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: ticagrelor
DRUG: clopidogrel

Sponsor

University Hospital, Toulouse